An organism consisting of a cell or cells in which the genetic material is DNA packaged into chromosomes, and contained within a distinct nucleus. All animals, plants and fungi are eukaryotes.
The Broad Institute, Cambridge, Massachusetts, has been awarded the US intellectual property rights for the use of CRISPR/Cas9 by a Patent and Trial Appeal Board...
The European Patent Office announced that it will uphold an earlier ruling to retract a key CRISPR/Cas9 patent held by the Broad Institute...
The US patent office has declared an 'interference' - re-opening the long-running dispute between the University of California (UC), Berkeley and the Broad Institute in Cambridge, Massachusetts, over who invented CRISPR genome editing first...
A US appeal court judgment in favour of the Broad Institute may mark the close of the long-running dispute over the US patent for the use of CRISPR/Cas9 in animal and plant cells...
Three scientists will share the US$1 million 2018 Kavli prize in Nanoscience 'for the invention of CRISPR-Cas9, a precise nanotool for editing DNA, causing a revolution in biology, agriculture, and medicine'...
After three years of intense legal battles over the patent rights to CRISPR genome editing technology, lawyers for the University of California Berkeley and the Broad Institute in Cambridge, Massachusetts faced off in court again...
The Broad Institute has filed arguments ahead of the upcoming CRISPR patent appeal hearing...
German-based company MilliporeSigma has announced that the European Patent Office intends to approve its CRISPR patent for use in eukaryotic cells...
The University of California has moved to appeal a decision of the US Patent Trial and Appeal Board over the use of CRISPR in eukaryotic cells...
China's State Intellectual Property Office has granted the University of California a patent on CRISPR-Cas9 gene editing technology in the country.
